PROGRAM
2nd European Course on Diagnosis and Management of RLS
Morning Session 1:
Chairpersons: Birgit Högl, Roselyne Rjisman
20-minute lectures followed by 10 minutes discussion with the audience (except brief overviews)
08:30 Welcome and Introduction
Birgit Högl (EURLSSG President), Innsbruck, Austria
08:45 Diagnosis of RLS, clinical course and comorbidities
Birgit Högl, Innsbruck, Austria
09:15 Brief overview: RLS pathophysiology and genetics
Barbara Schormair, Munich, Germany
09:30 Brief overview: Epidemiology of primary and symptomatic / comorbid forms
Klaus Berger, Muenster, Germany
09:45 RLS severity, diagnostic pathways, and mimics
Roselyne Rijsman, The Hague, The Netherlands
10:15 - Coffee Break -
Morning Session 2:
Chairpersons: Yves Dauvilliers, Klaus Berger
10:30 RLS therapeutic approaches:
Current guidelines and general introduction to pharmacological treatment options (15 min.)
Yves Dauvilliers, Montpellier, France
Managing RLS in renal failure, depression, and other comorbidities (15 min.)
Yves Davilliers, Montpellier, France
Controversy:
Dopamine agonists should be the first-line treatment for RLS (10 min.)
Mauro Manconi, Lugano, Switzerland
Alpha-2-delta ligands should be the first-line treatment for RLS (10 min.)
Diego Garcia-Borreguero, Madrid, Spain
11:45 What is augmentation, and how should it be managed?
Diego Garcia-Borreguero, Madrid, Spain
12:15 Guidelines for iron therapy
Rosalia Silvestri, Messina, Italy
12:45 The patient´s perspective
Daragh Bogan, London, UK
12:45 - Interactive Lunch Session-
An opportunity for participants to discuss difficult cases with an expert
Afternoon Session
Chairpersons: Mauro Manconi, Diego Garcia-Borreguero
14:00 Treatment guidelines in special conditions: pregnancy and children
Rosalia Silvestri, Messina, Italy
14:30 Interactive case discussions
Mauro Manconi, Lugano, Switzerland & Diego Garcia-Borreguero, Madrid, Spain
15:00 Q&A Session and closing remarks
Roselyne Rjisman, The Hague, The Netherlands & Mauro Manconi, Lugano, Switzerland
15:30 Close